MEDINDIA
English
हिन्दी
Español
français
中文
Email
4-Hydroxybutyric Acid
The risk or severity of adverse effects can be increased when Pethidine is combined with Gamma Hydroxybutyric Acid.
Abiraterone
The serum concentration of Pethidine can be increased when it is combined with Abiraterone.
Acepromazine
The risk or severity of adverse effects can be increased when Pethidine is combined with Acepromazine.
Aceprometazine
The risk or severity of adverse effects can be increased when Pethidine is combined with Aceprometazine.
Acetazolamide
The risk or severity of adverse effects can be increased when Pethidine is combined with Acetazolamide.
Acetophenazine
The risk or severity of adverse effects can be increased when Pethidine is combined with Acetophenazine.
Aclidinium
The risk or severity of adverse effects can be increased when Aclidinium is combined with Pethidine.
Alfaxalone
The risk or severity of adverse effects can be increased when Pethidine is combined with Alfaxalone.
Alfentanil
The risk or severity of adverse effects can be increased when Pethidine is combined with Alfentanil.
Almotriptan
The risk or severity of adverse effects can be increased when Pethidine is combined with Almotriptan.
Alogliptin
The risk or severity of adverse effects can be increased when Alogliptin is combined with Pethidine.
alpha 1-Antitrypsin
The risk or severity of adverse effects can be increased when Alpha-1-proteinase inhibitor is combined with Pethidine.
Alpha 1-Proteinase Inhibitor, Human
The risk or severity of adverse effects can be increased when Alpha-1-proteinase inhibitor is combined with Pethidine.
Alphaprodine
The risk or severity of adverse effects can be increased when Pethidine is combined with Alphaprodine.
Alprazolam
The risk or severity of adverse effects can be increased when Alprazolam is combined with Pethidine.
Alvimopan
The risk or severity of adverse effects can be increased when Pethidine is combined with Alvimopan.
Alvimopan Anhydrous
The risk or severity of adverse effects can be increased when Pethidine is combined with Alvimopan.
Amiloride
The risk or severity of adverse effects can be increased when Pethidine is combined with Amiloride.
Amiodarone
The metabolism of Pethidine can be decreased when combined with Amiodarone.
Amisulpride
The risk or severity of adverse effects can be increased when Pethidine is combined with Amisulpride.
Amitriptyline
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Pethidine.
Ammonium Chloride
Ammonium chloride may increase the excretion rate of Pethidine which could result in a lower serum level and potentially a reduction in efficacy.
Amobarbital
Amobarbital may increase the central nervous system depressant (CNS depressant) activities of Pethidine.
Amoxapine
The risk or severity of adverse effects can be increased when Pethidine is combined with Amoxapine.
Amphetamine
Amphetamine may increase the hypotensive and central nervous system depressant (CNS depressant) activities of Pethidine.
Amprenavir
The risk or severity of adverse effects can be increased when Amprenavir is combined with Pethidine.
Antithrombin III
The risk or severity of adverse effects can be increased when Antithrombin III human is combined with Pethidine.
Antithrombin III, Human
The risk or severity of adverse effects can be increased when Antithrombin III human is combined with Pethidine.
Apalutamide
The serum concentration of Pethidine can be decreased when it is combined with Apalutamide.
Apixaban
The risk or severity of adverse effects can be increased when Apixaban is combined with Pethidine.
Aprepitant
The serum concentration of Pethidine can be increased when it is combined with Aprepitant.
Aprotinin
The risk or severity of adverse effects can be increased when Aprotinin is combined with Pethidine.
Argatroban
The risk or severity of adverse effects can be increased when Argatroban is combined with Pethidine.
Argatroban Anhydrous
The risk or severity of adverse effects can be increased when Argatroban is combined with Pethidine.
Aripiprazole
The risk or severity of adverse effects can be increased when Pethidine is combined with Aripiprazole.
Armodafinil
The metabolism of Pethidine can be decreased when combined with Armodafinil.
Artemether
The metabolism of Pethidine can be decreased when combined with Artemether.
Articaine
The risk or severity of adverse effects can be increased when Pethidine is combined with Articaine.
Asenapine
The risk or severity of adverse effects can be increased when Pethidine is combined with Asenapine.
Asunaprevir
The risk or severity of adverse effects can be increased when Asunaprevir is combined with Pethidine.
Atazanavir
The risk or severity of adverse effects can be increased when Atazanavir is combined with Pethidine.
Atomoxetine
The metabolism of Pethidine can be decreased when combined with Atomoxetine.
Atracurium
The risk or severity of adverse effects can be increased when Atracurium is combined with Pethidine.
Atracurium Besylate
The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Pethidine.
Atropine
The risk or severity of adverse effects can be increased when Atropine is combined with Pethidine.
Azelastine
Pethidine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Azosemide
The risk or severity of adverse effects can be increased when Pethidine is combined with Azosemide.
Baclofen
The risk or severity of adverse effects can be increased when Pethidine is combined with Baclofen.
Barbexaclone
Barbexaclone may increase the central nervous system depressant (CNS depressant) activities of Pethidine.
Barbital
Barbital may increase the central nervous system depressant (CNS depressant) activities of Pethidine.
Benactyzine
The risk or severity of adverse effects can be increased when Benactyzine is combined with Pethidine.
Benazepril
The risk or severity of adverse effects can be increased when Benazepril is combined with Pethidine.
Bendroflumethiazide
The risk or severity of adverse effects can be increased when Pethidine is combined with Bendroflumethiazide.
Benoxinate
The risk or severity of adverse effects can be increased when Pethidine is combined with Oxybuprocaine.
Benperidol
The risk or severity of adverse effects can be increased when Pethidine is combined with Benperidol.
Benzocaine
The risk or severity of adverse effects can be increased when Pethidine is combined with Benzocaine.
Benzphetamine
Benzphetamine may increase the analgesic activities of Pethidine.
Benztropine
The risk or severity of adverse effects can be increased when Benzatropine is combined with Pethidine.
Benzyl Alcohol
The risk or severity of adverse effects can be increased when Pethidine is combined with Benzyl alcohol.
Betaxolol
The metabolism of Pethidine can be decreased when combined with Betaxolol.
Biperiden
The risk or severity of adverse effects can be increased when Biperiden is combined with Pethidine.
Bivalirudin
The risk or severity of adverse effects can be increased when Bivalirudin is combined with Pethidine.
Boceprevir
The risk or severity of adverse effects can be increased when Boceprevir is combined with Pethidine.
Bortezomib
The metabolism of Pethidine can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Pethidine can be decreased when it is combined with Bosentan.
Brexpiprazole
The risk or severity of adverse effects can be increased when Pethidine is combined with Brexpiprazole.
Brimonidine
Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Pethidine.
Bromazepam
The risk or severity of adverse effects can be increased when Pethidine is combined with Bromazepam.
Bromocriptine
The risk or severity of adverse effects can be increased when Pethidine is combined with Bromocriptine.
Bromperidol
The risk or severity of adverse effects can be increased when Pethidine is combined with Bromperidol.
Brompheniramine
The risk or severity of adverse effects can be increased when Pethidine is combined with Brompheniramine.
Brotizolam
The risk or severity of adverse effects can be increased when Pethidine is combined with Brotizolam.
Bumetanide
The risk or severity of adverse effects can be increased when Pethidine is combined with Bumetanide.
Bupivacaine
The risk or severity of adverse effects can be increased when Pethidine is combined with Bupivacaine.
Buprenorphine
Pethidine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Bupropion
The metabolism of Pethidine can be decreased when combined with Bupropion.
Buspirone
The risk or severity of adverse effects can be increased when Pethidine is combined with Buspirone.
Butabarbital
The risk or severity of adverse effects can be increased when Butabarbital is combined with Pethidine.
Butalbital
The risk or severity of adverse effects can be increased when Pethidine is combined with Butalbital.
Butamben
The risk or severity of adverse effects can be increased when Pethidine is combined with Butamben.
Butobarbital
The risk or severity of adverse effects can be increased when Pethidine is combined with Butethal.
Butorphanol
Butorphanol may decrease the analgesic activities of Pethidine.
Butylscopolamine
The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Pethidine.
Cabergoline
The risk or severity of adverse effects can be increased when Cabergoline is combined with Pethidine.
Canrenoate
The risk or severity of adverse effects can be increased when Pethidine is combined with Canrenoic acid.
Canrenoic Acid
The risk or severity of adverse effects can be increased when Pethidine is combined with Canrenoic acid.
Canrenone
The risk or severity of adverse effects can be increased when Pethidine is combined with Canrenone.
Captopril
The risk or severity of adverse effects can be increased when Captopril is combined with Pethidine.
Carbamazepine
The metabolism of Pethidine can be increased when combined with Carbamazepine.
Carbinoxamine
The risk or severity of adverse effects can be increased when Pethidine is combined with Carbinoxamine.
Cariprazine
The risk or severity of adverse effects can be increased when Pethidine is combined with Cariprazine.
Carisoprodol
The risk or severity of adverse effects can be increased when Pethidine is combined with Carisoprodol.
Celecoxib
The metabolism of Pethidine can be decreased when combined with Celecoxib.
Ceritinib
The serum concentration of Pethidine can be increased when it is combined with Ceritinib.
Cetirizine
The risk or severity of adverse effects can be increased when Pethidine is combined with Cetirizine.
Chloral Hydrate
The risk or severity of adverse effects can be increased when Pethidine is combined with Chloral hydrate.
Chloramphenicol
The metabolism of Pethidine can be decreased when combined with Chloramphenicol.
Chlordiazepoxide
The risk or severity of adverse effects can be increased when Pethidine is combined with Chlordiazepoxide.
Chlormethiazole
The risk or severity of adverse effects can be increased when Pethidine is combined with clomethiazole.
Chlormezanone
The risk or severity of adverse effects can be increased when Pethidine is combined with Chlormezanone.
Chloroprocaine
The risk or severity of adverse effects can be increased when Pethidine is combined with Chloroprocaine.
Chloroquine
The metabolism of Pethidine can be decreased when combined with Chloroquine.
Chlorothiazide
The risk or severity of adverse effects can be increased when Pethidine is combined with Chlorothiazide.
Chlorpheniramine
The risk or severity of adverse effects can be increased when Pethidine is combined with Chlorphenamine.
CHLORPHENIRAMINE POLISTIREX
The risk or severity of adverse effects can be increased when Pethidine is combined with Chlorphenamine.
Chlorphenoxamine
The risk or severity of adverse effects can be increased when Chlorphenoxamine is combined with Pethidine.
Chlorpromazine
The metabolism of Pethidine can be decreased when combined with Chlorpromazine.
Chlorprothixene
The risk or severity of adverse effects can be increased when Pethidine is combined with Chlorprothixene.
Chlorthalidone
The risk or severity of adverse effects can be increased when Pethidine is combined with Chlorthalidone.
Chlorzoxazone
The risk or severity of adverse effects can be increased when Pethidine is combined with Chlorzoxazone.
Cholecalciferol
The metabolism of Pethidine can be decreased when combined with Cholecalciferol.
Cholesterol
The risk or severity of adverse effects can be increased when Cholesterol is combined with Pethidine.
Cicletanine
The risk or severity of adverse effects can be increased when Pethidine is combined with Cicletanine.
Cilastatin
The risk or severity of adverse effects can be increased when Cilastatin is combined with Pethidine.
Cilazapril
The risk or severity of adverse effects can be increased when Cilazapril is combined with Pethidine.
Cimetidine
The serum concentration of Pethidine can be increased when it is combined with Cimetidine.
Cinacalcet
The metabolism of Pethidine can be decreased when combined with Cinacalcet.
Citalopram
The risk or severity of adverse effects can be increased when Citalopram is combined with Pethidine.
Clarithromycin
The metabolism of Pethidine can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Pethidine can be decreased when combined with Clemastine.
Clidinium
The risk or severity of adverse effects can be increased when Pethidine is combined with Clidinium.
Clidinium bromide
The risk or severity of adverse effects can be increased when Pethidine is combined with Clidinium.
Clobazam
The metabolism of Pethidine can be decreased when combined with Clobazam.
Clomipramine
The risk or severity of adverse effects can be increased when Pethidine is combined with Clomipramine.
Clonazepam
The risk or severity of adverse effects can be increased when Pethidine is combined with Clonazepam.
Clonidine
The risk or severity of adverse effects can be increased when Pethidine is combined with Clonidine.
Clopamide
The risk or severity of adverse effects can be increased when Pethidine is combined with Clopamide.
Clopidogrel
The metabolism of Pethidine can be decreased when combined with Clopidogrel.
Clorazepate
The risk or severity of adverse effects can be increased when Pethidine is combined with Clorazepate.
CLORAZEPIC ACID
The risk or severity of adverse effects can be increased when Pethidine is combined with Clorazepate.
Clotrimazole
The metabolism of Pethidine can be decreased when combined with Clotrimazole.
Clozapine
The metabolism of Pethidine can be decreased when combined with Clozapine.
Cobicistat
The serum concentration of Pethidine can be increased when it is combined with Cobicistat.
Cocaine
The metabolism of Pethidine can be decreased when combined with Cocaine.
Codeine
The risk or severity of adverse effects can be increased when Codeine is combined with Pethidine.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Codeine is combined with Pethidine.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Codeine is combined with Pethidine.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Pethidine.
Crizotinib
The metabolism of Pethidine can be decreased when combined with Crizotinib.
Cyamemazine
The risk or severity of adverse effects can be increased when Pethidine is combined with Cyamemazine.
Cyclizine
The risk or severity of adverse effects can be increased when Pethidine is combined with Cyclizine.
Cyclobenzaprine
The risk or severity of adverse effects can be increased when Pethidine is combined with Cyclobenzaprine.
Cyclopenthiazide
The risk or severity of adverse effects can be increased when Pethidine is combined with Cyclopenthiazide.
Cyclopentolate
The risk or severity of adverse effects can be increased when Cyclopentolate is combined with Pethidine.
Cyclosporine
The metabolism of Pethidine can be decreased when combined with Cyclosporine.
Cyclothiazide
The risk or severity of adverse effects can be increased when Pethidine is combined with Cyclothiazide.
Cyproheptadine
The risk or severity of adverse effects can be increased when Pethidine is combined with Cyproheptadine.
Dabigatran Etexilate
The risk or severity of adverse effects can be increased when Dabigatran etexilate is combined with Pethidine.
Dabrafenib
The serum concentration of Pethidine can be decreased when it is combined with Dabrafenib.
Dantrolene
The risk or severity of adverse effects can be increased when Pethidine is combined with Dantrolene.
Dapiprazole
The risk or severity of adverse effects can be increased when Pethidine is combined with Dapiprazole.
Darifenacin
The metabolism of Pethidine can be decreased when combined with Darifenacin.
Darunavir
The risk or severity of adverse effects can be increased when Darunavir is combined with Pethidine.
Dasatinib
The serum concentration of Pethidine can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Pethidine can be increased when it is combined with Dasatinib.
Deferasirox
The serum concentration of Pethidine can be decreased when it is combined with Deferasirox.
Delavirdine
The metabolism of Pethidine can be decreased when combined with Delavirdine.
Desflurane
The risk or severity of adverse effects can be increased when Pethidine is combined with Desflurane.
Desipramine
The risk or severity of adverse effects can be increased when Pethidine is combined with Desipramine.
Desloratadine
The risk or severity of adverse effects can be increased when Desloratadine is combined with Pethidine.
Desmopressin
The risk or severity of adverse effects can be increased when Pethidine is combined with Desmopressin.
Desvenlafaxine
The risk or severity of adverse effects can be increased when Pethidine is combined with Desvenlafaxine.
Dexbrompheniramine
The risk or severity of adverse effects can be increased when Pethidine is combined with Dexbrompheniramine.
Dexetimide
The risk or severity of adverse effects can be increased when Dexetimide is combined with Pethidine.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Pethidine is combined with Dexmedetomidine.
Dextroamphetamine
Dextroamphetamine may increase the analgesic activities of Pethidine.
Dextromethorphan
The risk or severity of adverse effects can be increased when Pethidine is combined with Dextromethorphan.
Dextromoramide
The risk or severity of adverse effects can be increased when Pethidine is combined with Dextromoramide.
Dezocine
The risk or severity of adverse effects can be increased when Pethidine is combined with Dezocine.
Diazepam
The risk or severity of adverse effects can be increased when Pethidine is combined with Diazepam.
Dibucaine
The risk or severity of adverse effects can be increased when Pethidine is combined with Cinchocaine.
Dicyclomine
The risk or severity of adverse effects can be increased when Dicyclomine is combined with Pethidine.
Diethylpropion
Diethylpropion may increase the analgesic activities of Pethidine.
Difenoxin
The risk or severity of adverse effects can be increased when Pethidine is combined with Difenoxin.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Pethidine is combined with Dihydrocodeine.
Dihydroergotamine
The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Pethidine.
Diltiazem
The metabolism of Pethidine can be decreased when combined with Diltiazem.
Dimenhydrinate
The risk or severity of adverse effects can be increased when Pethidine is combined with Dimenhydrinate.
Diphenhydramine
The metabolism of Pethidine can be decreased when combined with Diphenhydramine.
Diphenoxylate
The risk or severity of adverse effects can be increased when Pethidine is combined with Diphenoxylate.
Dolasetron
Dolasetron may increase the serotonergic activities of Pethidine.
Dothiepin
The metabolism of Pethidine can be decreased when combined with Dosulepin.
Doxepin
The risk or severity of adverse effects can be increased when Pethidine is combined with Doxepin.
Doxorubicin
The metabolism of Pethidine can be decreased when combined with Doxorubicin.
Doxorubicin Hydrochloride
The metabolism of Pethidine can be decreased when combined with Doxorubicin.
Doxycycline
The metabolism of Pethidine can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Pethidine can be decreased when combined with Doxycycline.
Doxylamine
Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Pethidine.
Dronedarone
The metabolism of Pethidine can be decreased when combined with Dronedarone.
Droperidol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Pethidine.
Drospirenone
The risk or severity of adverse effects can be increased when Pethidine is combined with Drospirenone.
Duloxetine
The risk or severity of adverse effects can be increased when Pethidine is combined with Duloxetine.
Dyclonine
The risk or severity of adverse effects can be increased when Pethidine is combined with Dyclonine.
Edoxaban
The risk or severity of adverse effects can be increased when Edoxaban is combined with Pethidine.
Efavirenz
The metabolism of Pethidine can be decreased when combined with Efavirenz.
Eletriptan
The risk or severity of adverse effects can be increased when Eletriptan is combined with Pethidine.
Eliglustat
The metabolism of Pethidine can be decreased when combined with Eliglustat.
Eluxadoline
Pethidine may increase the constipating activities of Eluxadoline.
Enalapril
The risk or severity of adverse effects can be increased when Enalapril is combined with Pethidine.
Enalaprilat
The risk or severity of adverse effects can be increased when Enalaprilat is combined with Pethidine.
Enalaprilat Anhydrous
The risk or severity of adverse effects can be increased when Enalaprilat is combined with Pethidine.
Enflurane
The risk or severity of adverse effects can be increased when Pethidine is combined with Enflurane.
Entacapone
The risk or severity of adverse effects can be increased when Pethidine is combined with Entacapone.
Enzalutamide
The serum concentration of Pethidine can be decreased when it is combined with Enzalutamide.
Epigallocatechin Gallate
The risk or severity of adverse effects can be increased when Epigallocatechin Gallate is combined with Pethidine.
Eplerenone
The risk or severity of adverse effects can be increased when Pethidine is combined with Eplerenone.
ergoloid mesylates, USP
The risk or severity of adverse effects can be increased when Pethidine is combined with Ergoloid mesylate.
Ergonovine
The risk or severity of adverse effects can be increased when Pethidine is combined with Ergonovine.
Ergotamine
The risk or severity of adverse effects can be increased when Pethidine is combined with Ergotamine.
Erythromycin
The metabolism of Pethidine can be decreased when combined with Erythromycin.
Escitalopram
The risk or severity of adverse effects can be increased when Pethidine is combined with Escitalopram.
Eslicarbazepine Acetate
The metabolism of Pethidine can be decreased when combined with Eslicarbazepine acetate.
Esomeprazole
The metabolism of Pethidine can be decreased when combined with Esomeprazole.
Estazolam
The risk or severity of adverse effects can be increased when Pethidine is combined with Estazolam.
Eszopiclone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Pethidine.
Ethacrynate
The risk or severity of adverse effects can be increased when Pethidine is combined with Etacrynic acid.
Ethacrynic Acid
The risk or severity of adverse effects can be increased when Pethidine is combined with Etacrynic acid.
Ethanol
Pethidine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Ethchlorvynol
The risk or severity of adverse effects can be increased when Pethidine is combined with Ethchlorvynol.
Ethosuximide
The risk or severity of adverse effects can be increased when Pethidine is combined with Ethosuximide.
Ethotoin
The risk or severity of adverse effects can be increased when Pethidine is combined with Ethotoin.
Ethyl Chloride
The risk or severity of adverse effects can be increased when Pethidine is combined with Ethyl chloride.
Ethyl Loflazepate
The risk or severity of adverse effects can be increased when Pethidine is combined with Ethyl loflazepate.
Ethylmorphine
The risk or severity of adverse effects can be increased when Pethidine is combined with Ethylmorphine.
Etidocaine
The risk or severity of adverse effects can be increased when Pethidine is combined with Etidocaine.
Etifoxine
The risk or severity of adverse effects can be increased when Pethidine is combined with Etifoxine.
Etomidate
The risk or severity of adverse effects can be increased when Pethidine is combined with Etomidate.
Etravirine
The metabolism of Pethidine can be decreased when combined with Etravirine.
Ezogabine
The risk or severity of adverse effects can be increased when Pethidine is combined with Ezogabine.
Felbamate
The risk or severity of adverse effects can be increased when Pethidine is combined with Felbamate.
Fentanyl
The risk or severity of adverse effects can be increased when Pethidine is combined with Fentanyl.
Fesoterodine
The risk or severity of adverse effects can be increased when Fesoterodine is combined with Pethidine.
Fexofenadine
The risk or severity of adverse effects can be increased when Pethidine is combined with Fexofenadine.
Fibrinolysis Inhibitor
The risk or severity of adverse effects can be increased when Aprotinin is combined with Pethidine.
Flibanserin
The risk or severity of adverse effects can be increased when Pethidine is combined with Flibanserin.
Fluconazole
The metabolism of Pethidine can be decreased when combined with Fluconazole.
Flunarizine
The risk or severity of adverse effects can be increased when Pethidine is combined with Flunarizine.
Flunitrazepam
The risk or severity of adverse effects can be increased when Pethidine is combined with Flunitrazepam.
Fluoxetine
The metabolism of Pethidine can be decreased when combined with Fluoxetine.
Flupenthixol
The risk or severity of adverse effects can be increased when Pethidine is combined with Flupentixol.
Fluphenazine
The risk or severity of adverse effects can be increased when Pethidine is combined with Fluphenazine.
Flurazepam
The risk or severity of adverse effects can be increased when Pethidine is combined with Flurazepam.
Fluspirilene
The risk or severity of adverse effects can be increased when Pethidine is combined with Fluspirilene.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Pethidine is combined with Fluticasone propionate.
Fluvoxamine
The metabolism of Pethidine can be decreased when combined with Fluvoxamine.
Fosamprenavir
The risk or severity of adverse effects can be increased when Fosamprenavir is combined with Pethidine.
Fosaprepitant
The serum concentration of Pethidine can be increased when it is combined with Fosaprepitant.
Fosinopril
The risk or severity of adverse effects can be increased when Fosinopril is combined with Pethidine.
Fosphenytoin
The serum concentration of Pethidine can be decreased when it is combined with Fosphenytoin.
Fospropofol
The risk or severity of adverse effects can be increased when Pethidine is combined with Fospropofol.
Frovatriptan
The risk or severity of adverse effects can be increased when Pethidine is combined with Frovatriptan.
Furazolidone
Furazolidone may increase the hypotensive and central nervous system depressant (CNS depressant) activities of Pethidine.
Furosemide
The risk or severity of adverse effects can be increased when Pethidine is combined with Furosemide.
Fusidate
The serum concentration of Pethidine can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Pethidine can be increased when it is combined with Fusidic Acid.
Gabapentin
The risk or severity of adverse effects can be increased when Pethidine is combined with Gabapentin.
Gabapentin Enacarbil
The risk or severity of adverse effects can be increased when Pethidine is combined with Gabapentin Enacarbil.
Gallamine Triethiodide
The risk or severity of adverse effects can be increased when Gallamine Triethiodide is combined with Pethidine.
Gemfibrozil
The metabolism of Pethidine can be decreased when combined with Gemfibrozil.
Glutethimide
The risk or severity of adverse effects can be increased when Pethidine is combined with Glutethimide.
Glycopyrronium
The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Pethidine.
Granisetron
Granisetron may increase the serotonergic activities of Pethidine.
Guanfacine
The risk or severity of adverse effects can be increased when Pethidine is combined with Guanfacine.
Halazepam
The risk or severity of adverse effects can be increased when Pethidine is combined with Halazepam.
Haloperidol
The metabolism of Pethidine can be decreased when combined with Haloperidol.
Halothane
The risk or severity of adverse effects can be increased when Pethidine is combined with Halothane.
Heroin
The risk or severity of adverse effects can be increased when Pethidine is combined with Heroin.
Hexobarbital
Hexobarbital may increase the central nervous system depressant (CNS depressant) activities of Pethidine.
Homatropine
The risk or severity of adverse effects can be increased when Homatropine is combined with Pethidine.
Hydrochlorothiazide
The risk or severity of adverse effects can be increased when Pethidine is combined with Hydrochlorothiazide.
Hydrocodone
Pethidine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
HYDROCODONE POLISTIREX
Pethidine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydroflumethiazide
The risk or severity of adverse effects can be increased when Pethidine is combined with Hydroflumethiazide.
Hydromorphone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Pethidine.
Hydroxyzine
Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Pethidine.
Hyoscyamine
The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Pethidine.
Hypoxis hemerocallidea root extract
The serum concentration of Pethidine can be decreased when it is combined with St. John's Wort.
Idelalisib
The metabolism of Pethidine can be decreased when combined with Idelalisib.
Iloperidone
The risk or severity of adverse effects can be increased when Pethidine is combined with Iloperidone.
Imatinib
The metabolism of Pethidine can be decreased when combined with Imatinib.
Imidapril
The risk or severity of adverse effects can be increased when Imidapril is combined with Pethidine.
Imipramine
The risk or severity of adverse effects can be increased when Pethidine is combined with Imipramine.
Indapamide
The risk or severity of adverse effects can be increased when Pethidine is combined with Indapamide.
Indinavir
The risk or severity of adverse effects can be increased when Indinavir is combined with Pethidine.
INDINAVIR ANHYDROUS
The risk or severity of adverse effects can be increased when Indinavir is combined with Pethidine.
Ipratropium Bromide
The risk or severity of adverse effects can be increased when Ipratropium bromide is combined with Pethidine.
Ipratropium Bromide Anhydrous
The risk or severity of adverse effects can be increased when Ipratropium bromide is combined with Pethidine.
Iproniazid
Iproniazid may increase the hypotensive and central nervous system depressant (CNS depressant) activities of Pethidine.
Isavuconazole
The serum concentration of Pethidine can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Pethidine can be decreased when combined with Isavuconazonium.
Isocarboxazid
Isocarboxazid may increase the hypotensive and central nervous system depressant (CNS depressant) activities of Pethidine.
Isoflurane
The risk or severity of adverse effects can be increased when Pethidine is combined with Isoflurane.
Isoflurophate
The risk or severity of adverse effects can be increased when Isoflurophate is combined with Pethidine.
Isoniazid
The metabolism of Pethidine can be decreased when combined with Isoniazid.
Isosorbide
The risk or severity of adverse effects can be increased when Pethidine is combined with Isosorbide.
Isradipine
The metabolism of Pethidine can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Pethidine can be decreased when combined with Itraconazole.
Ivacaftor
The serum concentration of Pethidine can be increased when it is combined with Ivacaftor.
Ixazomib
The risk or severity of adverse effects can be increased when Ixazomib is combined with Pethidine.
Ketamine
The risk or severity of adverse effects can be increased when Pethidine is combined with Ketamine.
Ketazolam
The risk or severity of adverse effects can be increased when Pethidine is combined with Ketazolam.
Ketoconazole
The metabolism of Pethidine can be decreased when combined with Ketoconazole.
Lamotrigine
The risk or severity of adverse effects can be increased when Pethidine is combined with Lamotrigine.
Lepirudin
The risk or severity of adverse effects can be increased when Lepirudin is combined with Pethidine.
Levetiracetam
The risk or severity of adverse effects can be increased when Pethidine is combined with Levetiracetam.
Levobupivacaine
The risk or severity of adverse effects can be increased when Pethidine is combined with Levobupivacaine.
Levocabastine
The risk or severity of adverse effects can be increased when Pethidine is combined with Levocabastine.
Levocetirizine
The risk or severity of adverse effects can be increased when Pethidine is combined with Levocetirizine.
Levodopa
The risk or severity of adverse effects can be increased when Pethidine is combined with Levodopa.
Levomethadyl
The risk or severity of adverse effects can be increased when Pethidine is combined with Levomethadyl Acetate.
Levomilnacipran
The risk or severity of adverse effects can be increased when Pethidine is combined with Levomilnacipran.
Levorphanol
The risk or severity of adverse effects can be increased when Pethidine is combined with Levorphanol.
Lidocaine
The risk or severity of adverse effects can be increased when Pethidine is combined with Lidocaine.
Linagliptin
The risk or severity of adverse effects can be increased when Linagliptin is combined with Pethidine.
Linezolid
The risk or severity of adverse effects can be increased when Pethidine is combined with Linezolid.
Lisdexamfetamine
Lisdexamfetamine may increase the analgesic activities of Pethidine.
Lisdexamfetamine Dimesylate
Lisdexamfetamine may increase the analgesic activities of Pethidine.
Lisinopril
The risk or severity of adverse effects can be increased when Lisinopril is combined with Pethidine.
Lisinopril Anhydrous
The risk or severity of adverse effects can be increased when Lisinopril is combined with Pethidine.
Lithium
The risk or severity of adverse effects can be increased when Pethidine is combined with Lithium.
Lithium Cation
The risk or severity of adverse effects can be increased when Pethidine is combined with Lithium.
Lopinavir
The risk or severity of adverse effects can be increased when Lopinavir is combined with Pethidine.
Loratadine
The risk or severity of adverse effects can be increased when Pethidine is combined with Loratadine.
Lorazepam
The risk or severity of adverse effects can be increased when Lorazepam is combined with Pethidine.
Lorcaserin
The risk or severity of adverse effects can be increased when Pethidine is combined with Lorcaserin.
Lormetazepam
The risk or severity of adverse effects can be increased when Pethidine is combined with Lormetazepam.
Lovastatin
The metabolism of Pethidine can be decreased when combined with Lovastatin.
Loxapine
The risk or severity of adverse effects can be increased when Loxapine is combined with Pethidine.
Luliconazole
The serum concentration of Pethidine can be increased when it is combined with Luliconazole.
Lumacaftor
The serum concentration of Pethidine can be decreased when it is combined with Lumacaftor.
Lumefantrine
The metabolism of Pethidine can be decreased when combined with Lumefantrine.
Lurasidone
The risk or severity of adverse effects can be increased when Pethidine is combined with Lurasidone.
Magnesium Sulfate
The therapeutic efficacy of Pethidine can be increased when used in combination with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The therapeutic efficacy of Pethidine can be increased when used in combination with Magnesium sulfate.
Manidipine
The metabolism of Pethidine can be decreased when combined with Manidipine.
Mannitol
The risk or severity of adverse effects can be increased when Pethidine is combined with Mannitol.
Maprotiline
The risk or severity of adverse effects can be increased when Pethidine is combined with Maprotiline.
Mecamylamine
The risk or severity of adverse effects can be increased when Mecamylamine is combined with Pethidine.
Meclizine
The risk or severity of adverse effects can be increased when Pethidine is combined with Meclizine.
Melatonin
The risk or severity of adverse effects can be increased when Pethidine is combined with Melatonin.
Mephentermine
Mephentermine may increase the analgesic activities of Pethidine.
Mephobarbital
Methylphenobarbital may increase the central nervous system depressant (CNS depressant) activities of Pethidine.
Mepivacaine
The risk or severity of adverse effects can be increased when Pethidine is combined with Mepivacaine.
Meprobamate
The risk or severity of adverse effects can be increased when Meprobamate is combined with Pethidine.
Mersalyl
The risk or severity of adverse effects can be increased when Pethidine is combined with Mersalyl.
Mesoridazine
The risk or severity of adverse effects can be increased when Pethidine is combined with Mesoridazine.
Metaxalone
The risk or severity of adverse effects can be increased when Pethidine is combined with Metaxalone.
Methadone
The risk or severity of adverse effects can be increased when Methadone is combined with Pethidine.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Pethidine is combined with Methadyl Acetate.
Methamphetamine
Methamphetamine may increase the analgesic activities of Pethidine.
Methantheline
The risk or severity of adverse effects can be increased when Methantheline is combined with Pethidine.
Methapyrilene
The risk or severity of adverse effects can be increased when Pethidine is combined with Methapyrilene.
Methaqualone
The risk or severity of adverse effects can be increased when Pethidine is combined with Methaqualone.
Methazolamide
The risk or severity of adverse effects can be increased when Pethidine is combined with Methazolamide.
Methixene
The risk or severity of adverse effects can be increased when Metixene is combined with Pethidine.
Methocarbamol
The risk or severity of adverse effects can be increased when Pethidine is combined with Methocarbamol.
Methohexital
Methohexital may increase the central nervous system depressant (CNS depressant) activities of Pethidine.
Methotrimeprazine
Pethidine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Methoxyflurane
The risk or severity of adverse effects can be increased when Pethidine is combined with Methoxyflurane.
Methscopolamine Bromide
The risk or severity of adverse effects can be increased when Methylscopolamine bromide is combined with Pethidine.
Methsuximide
The risk or severity of adverse effects can be increased when Pethidine is combined with Methsuximide.
Methyclothiazide
The risk or severity of adverse effects can be increased when Pethidine is combined with Methyclothiazide.
Methylene blue
Methylene blue may increase the hypotensive and central nervous system depressant (CNS depressant) activities of Pethidine.
Metoclopramide
The risk or severity of adverse effects can be increased when Pethidine is combined with Metoclopramide.
Metolazone
The risk or severity of adverse effects can be increased when Pethidine is combined with Metolazone.
Metoprolol
The metabolism of Pethidine can be decreased when combined with Metoprolol.
Metylperon
The risk or severity of adverse effects can be increased when Pethidine is combined with Melperone.
Metyrosine
Pethidine may increase the sedative activities of Metyrosine.
Midazolam
The risk or severity of adverse effects can be increased when Pethidine is combined with Midazolam.
Midostaurin
The metabolism of Pethidine can be decreased when combined with Midostaurin.
Mifepristone
The serum concentration of Pethidine can be increased when it is combined with Mifepristone.
Milnacipran
The risk or severity of adverse effects can be increased when Pethidine is combined with Milnacipran.
Minaprine
Minaprine may increase the hypotensive and central nervous system depressant (CNS depressant) activities of Pethidine.
Minocycline
Minocycline may increase the central nervous system depressant (CNS depressant) activities of Pethidine.
Mirabegron
The metabolism of Pethidine can be decreased when combined with Mirabegron.
Mirtazapine
Pethidine may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Mitotane
The serum concentration of Pethidine can be decreased when it is combined with Mitotane.
Moclobemide
Moclobemide may increase the hypotensive and central nervous system depressant (CNS depressant) activities of Pethidine.
Modafinil
The metabolism of Pethidine can be decreased when combined with Modafinil.
Moexipril
The risk or severity of adverse effects can be increased when Moexipril is combined with Pethidine.
Molindone
The risk or severity of adverse effects can be increased when Pethidine is combined with Molindone.
Moricizine
Moricizine may increase the hypotensive activities of Pethidine.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Pethidine.
Nabilone
Nabilone may increase the central nervous system depressant (CNS depressant) activities of Pethidine.
Nalbuphine
Nalbuphine may decrease the analgesic activities of Pethidine.
Naltrexone
The therapeutic efficacy of Pethidine can be decreased when used in combination with Naltrexone.
Naratriptan
The risk or severity of adverse effects can be increased when Pethidine is combined with Naratriptan.
Nefazodone
The metabolism of Pethidine can be decreased when combined with Nefazodone.
Nelfinavir
The risk or severity of adverse effects can be increased when Nelfinavir is combined with Pethidine.
Netupitant
The serum concentration of Pethidine can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Pethidine can be increased when combined with Nevirapine.
Nialamide
Nialamide may increase the hypotensive and central nervous system depressant (CNS depressant) activities of Pethidine.
Nicardipine
The metabolism of Pethidine can be decreased when combined with Nicardipine.
Nilotinib
The metabolism of Pethidine can be decreased when combined with Nilotinib.
Nitrazepam
The risk or severity of adverse effects can be increased when Pethidine is combined with Nitrazepam.
Nitrous Oxide
The risk or severity of adverse effects can be increased when Pethidine is combined with Nitrous oxide.
Norflurane
The risk or severity of adverse effects can be increased when Pethidine is combined with Norflurane.
Normethadone
The risk or severity of adverse effects can be increased when Pethidine is combined with Normethadone.
Nortriptyline
The risk or severity of adverse effects can be increased when Pethidine is combined with Nortriptyline.
O-PHENANTHROLINE
The risk or severity of adverse effects can be increased when 1,10-Phenanthroline is combined with Pethidine.
Octotropine Methylbromide
The risk or severity of adverse effects can be increased when Anisotropine Methylbromide is combined with Pethidine.
Octylonium
The risk or severity of adverse effects can be increased when Otilonium is combined with Pethidine.
Olanzapine
The risk or severity of adverse effects can be increased when Olanzapine is combined with Pethidine.
Olaparib
The metabolism of Pethidine can be decreased when combined with Olaparib.
Olopatadine
The risk or severity of adverse effects can be increased when Pethidine is combined with Olopatadine.
Omeprazole
The metabolism of Pethidine can be decreased when combined with Omeprazole.
Ondansetron
The risk or severity of adverse effects can be increased when Pethidine is combined with Ondansetron.
Opium
The risk or severity of adverse effects can be increased when Pethidine is combined with Opium.
Orphenadrine
Pethidine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Osimertinib
The serum concentration of Pethidine can be increased when it is combined with Osimertinib.
Oxazepam
The risk or severity of adverse effects can be increased when Pethidine is combined with Oxazepam.
Oxitropium
The risk or severity of adverse effects can be increased when Oxitropium is combined with Pethidine.
Oxprenolol
The risk or severity of adverse effects can be increased when Pethidine is combined with Oxprenolol.
Oxybutynin
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Pethidine.
Oxycodone
The risk or severity of adverse effects can be increased when Pethidine is combined with Oxycodone.
Oxymorphone
The risk or severity of adverse effects can be increased when Pethidine is combined with Oxymorphone.
Oxyphenonium
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Pethidine.
p-Hydroxyamphetamine
Hydroxyamphetamine may increase the analgesic activities of Pethidine.
Palbociclib
The serum concentration of Pethidine can be increased when it is combined with Palbociclib.
Paliperidone
The risk or severity of adverse effects can be increased when Pethidine is combined with Paliperidone.
Palonosetron
Palonosetron may increase the serotonergic activities of Pethidine.
Pamabrom
The risk or severity of adverse effects can be increased when Pethidine is combined with Pamabrom.
Pancuronium
The risk or severity of adverse effects can be increased when Pancuronium is combined with Pethidine.
Pancuronium Bromide
The risk or severity of adverse effects can be increased when Pancuronium is combined with Pethidine.
Panobinostat
The serum concentration of Pethidine can be increased when it is combined with Panobinostat.
Pantoprazole
The metabolism of Pethidine can be decreased when combined with Pantoprazole.
Paraldehyde
Pethidine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Pethidine.
Pargyline
Pargyline may increase the hypotensive and central nervous system depressant (CNS depressant) activities of Pethidine.
Paroxetine
The metabolism of Pethidine can be decreased when combined with Paroxetine.
Peginterferon Alfa-2b
The serum concentration of Pethidine can be decreased when it is combined with Peginterferon alfa-2b.
Pegvisomant
The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Pethidine.
Pentazocine
Pentazocine may decrease the analgesic activities of Pethidine.
Pentobarbital
Pentobarbital may increase the central nervous system depressant (CNS depressant) activities of Pethidine.
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Pethidine.
Perazine
The risk or severity of adverse effects can be increased when Pethidine is combined with Perazine.
Periciazine
Propericiazine may increase the hypotensive activities of Pethidine.
Perindopril
The risk or severity of adverse effects can be increased when Perindopril is combined with Pethidine.
Perphenazine
The risk or severity of adverse effects can be increased when Pethidine is combined with Perphenazine.
Phenelzine
Phenelzine may increase the hypotensive and central nervous system depressant (CNS depressant) activities of Pethidine.
Phenobarbital
Phenobarbital may increase the central nervous system depressant (CNS depressant) activities of Pethidine.
Phenoxyethanol
The risk or severity of adverse effects can be increased when Pethidine is combined with Phenoxyethanol.
Phentermine
Phentermine may increase the analgesic activities of Pethidine.
PHENTERMINE RESIN
Phentermine may increase the analgesic activities of Pethidine.
Phenytoin
The serum concentration of Pethidine can be decreased when it is combined with Phenytoin.
Pimozide
The risk or severity of adverse effects can be increased when Pethidine is combined with Pimozide.
Pipamperone
The risk or severity of adverse effects can be increased when Pethidine is combined with Pipamperone.
Pipecuronium
The risk or severity of adverse effects can be increased when Pipecuronium is combined with Pethidine.
Pipothiazine
The risk or severity of adverse effects can be increased when Pethidine is combined with Pipotiazine.
Pirenzepine
The risk or severity of adverse effects can be increased when Pirenzepine is combined with Pethidine.
Piretanide
The risk or severity of adverse effects can be increased when Pethidine is combined with Piretanide.
Pirinitramide
The risk or severity of adverse effects can be increased when Pethidine is combined with Piritramide.
Pizotyline
The risk or severity of adverse effects can be increased when Pethidine is combined with Pizotifen.
Polythiazide
The risk or severity of adverse effects can be increased when Pethidine is combined with Polythiazide.
Pomalidomide
The risk or severity of adverse effects can be increased when Pethidine is combined with Pomalidomide.
Posaconazole
The metabolism of Pethidine can be decreased when combined with Posaconazole.
Potassium
The risk or severity of adverse effects can be increased when Pethidine is combined with Potassium.
Potassium Citrate
The risk or severity of adverse effects can be increased when Pethidine is combined with Potassium Citrate.
Pramipexole
Pethidine may increase the sedative activities of Pramipexole.
Pramoxine
The risk or severity of adverse effects can be increased when Pethidine is combined with Pramocaine.
Prazepam
The risk or severity of adverse effects can be increased when Pethidine is combined with Prazepam.
Pregabalin
The therapeutic efficacy of Pethidine can be increased when used in combination with Pregabalin.
Prilocaine
The risk or severity of adverse effects can be increased when Pethidine is combined with Prilocaine.
Primidone
Primidone may increase the central nervous system depressant (CNS depressant) activities of Pethidine.
Procaine
The risk or severity of adverse effects can be increased when Pethidine is combined with Procaine.
Procarbazine
Procarbazine may increase the hypotensive and central nervous system depressant (CNS depressant) activities of Pethidine.
Prochlorperazine
The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Pethidine.
Procyclidine
The risk or severity of adverse effects can be increased when Procyclidine is combined with Pethidine.
Profenamine
The risk or severity of adverse effects can be increased when Ethopropazine is combined with Pethidine.
Promazine
The metabolism of Pethidine can be decreased when combined with Promazine.
Promethazine
The risk or severity of adverse effects can be increased when Pethidine is combined with Promethazine.
Propantheline
The risk or severity of adverse effects can be increased when Propantheline is combined with Pethidine.
Propantheline Bromide
The risk or severity of adverse effects can be increased when Propantheline is combined with Pethidine.
Proparacaine
The risk or severity of adverse effects can be increased when Pethidine is combined with Proparacaine.
Propiverine
The risk or severity of adverse effects can be increased when Propiverine is combined with Pethidine.
Propofol
The risk or severity of adverse effects can be increased when Pethidine is combined with Propofol.
Propoxyphene
The risk or severity of adverse effects can be increased when Pethidine is combined with Dextropropoxyphene.
Prothipendyl
The risk or severity of adverse effects can be increased when Pethidine is combined with Prothipendyl.
Protriptyline
The risk or severity of adverse effects can be increased when Protriptyline is combined with Pethidine.
Pseudoephedrine
Pseudoephedrine may increase the analgesic activities of Pethidine.
Quazepam
The serum concentration of Pethidine can be increased when it is combined with Quazepam.
Quetiapine
The risk or severity of adverse effects can be increased when Pethidine is combined with Quetiapine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Pethidine is combined with Quetiapine.
Quinapril
The risk or severity of adverse effects can be increased when Quinapril is combined with Pethidine.
Quinethazone
The risk or severity of adverse effects can be increased when Pethidine is combined with Quinethazone.
Quinidine
The metabolism of Pethidine can be decreased when combined with Quinidine.
Quinine
The metabolism of Pethidine can be decreased when combined with Quinine.
Racecadotril
The risk or severity of adverse effects can be increased when Racecadotril is combined with Pethidine.
Ramelteon
The risk or severity of adverse effects can be increased when Pethidine is combined with Ramelteon.
Ramipril
The risk or severity of adverse effects can be increased when Ramipril is combined with Pethidine.
Ranolazine
The metabolism of Pethidine can be decreased when combined with Ranolazine.
Rasagiline
Rasagiline may increase the hypotensive and central nervous system depressant (CNS depressant) activities of Pethidine.
Remifentanil
The risk or severity of adverse effects can be increased when Pethidine is combined with Remifentanil.
Remoxipride
The risk or severity of adverse effects can be increased when Pethidine is combined with Remoxipride.
Reserpine
The risk or severity of adverse effects can be increased when Reserpine is combined with Pethidine.
Rifabutin
The metabolism of Pethidine can be increased when combined with Rifabutin.
Rifampin
The metabolism of Pethidine can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Pethidine can be increased when combined with Rifapentine.
Rilpivirine
The serum concentration of Pethidine can be decreased when it is combined with Rilpivirine.
Risperidone
The risk or severity of adverse effects can be increased when Pethidine is combined with Risperidone.
Ritonavir
The risk or severity of adverse effects can be increased when Ritonavir is combined with Pethidine.
Rivaroxaban
The risk or severity of adverse effects can be increased when Rivaroxaban is combined with Pethidine.
Rizatriptan
The risk or severity of adverse effects can be increased when Pethidine is combined with Rizatriptan.
Rolapitant
The metabolism of Pethidine can be decreased when combined with Rolapitant.
Ropinirole
Pethidine may increase the sedative activities of Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Pethidine is combined with Ropivacaine.
Rotigotine
Pethidine may increase the sedative activities of Rotigotine.
Rucaparib
The metabolism of Pethidine can be decreased when combined with Rucaparib.
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Pethidine.
Saquinavir
The risk or severity of adverse effects can be increased when Saquinavir is combined with Pethidine.
Saquinavir Mesylate
The risk or severity of adverse effects can be increased when Saquinavir is combined with Pethidine.
Sarilumab
The therapeutic efficacy of Pethidine can be decreased when used in combination with Sarilumab.
Saxagliptin
The risk or severity of adverse effects can be increased when Saxagliptin is combined with Pethidine.
Saxagliptin Anhydrous
The risk or severity of adverse effects can be increased when Saxagliptin is combined with Pethidine.
Scopolamine
The risk or severity of adverse effects can be increased when Scopolamine is combined with Pethidine.
Scopolamine Hydrobromide
The risk or severity of adverse effects can be increased when Scopolamine is combined with Pethidine.
Secobarbital
Secobarbital may increase the central nervous system depressant (CNS depressant) activities of Pethidine.
Selegiline
Selegiline may increase the hypotensive and central nervous system depressant (CNS depressant) activities of Pethidine.
Sertindole
The risk or severity of adverse effects can be increased when Pethidine is combined with Sertindole.
Sertraline
The risk or severity of adverse effects can be increased when Pethidine is combined with Sertraline.
Sevoflurane
The risk or severity of adverse effects can be increased when Pethidine is combined with Sevoflurane.
Sildenafil
The metabolism of Pethidine can be decreased when combined with Sildenafil.
Siltuximab
The serum concentration of Pethidine can be decreased when it is combined with Siltuximab.
Simeprevir
The risk or severity of adverse effects can be increased when Simeprevir is combined with Pethidine.
Sitagliptin
The risk or severity of adverse effects can be increased when Sitagliptin is combined with Pethidine.
Sitagliptin Phosphate
The risk or severity of adverse effects can be increased when Sitagliptin is combined with Pethidine.
Sodium Oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Pethidine.
Solifenacin
The risk or severity of adverse effects can be increased when Solifenacin is combined with Pethidine.
Sorafenib
The metabolism of Pethidine can be decreased when combined with Sorafenib.
Spirapril
The risk or severity of adverse effects can be increased when Spirapril is combined with Pethidine.
Spironolactone
The risk or severity of adverse effects can be increased when Pethidine is combined with Spironolactone.
ST. JOHN'S WORT EXTRACT
The serum concentration of Pethidine can be decreased when it is combined with St. John's Wort.
Succinylcholine
Succinylcholine may increase the bradycardic activities of Pethidine.
Sufentanil
The risk or severity of adverse effects can be increased when Pethidine is combined with Sufentanil.
Sulfisoxazole
The metabolism of Pethidine can be decreased when combined with Sulfisoxazole.
Sulpiride
The risk or severity of adverse effects can be increased when Pethidine is combined with Sulpiride.
Sumatriptan
The risk or severity of adverse effects can be increased when Pethidine is combined with Sumatriptan.
Sumatriptan Succinate
The risk or severity of adverse effects can be increased when Pethidine is combined with Sumatriptan.
Suvorexant
Pethidine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Pethidine.
Tasimelteon
The risk or severity of adverse effects can be increased when Pethidine is combined with Tasimelteon.
Tedizolid
Tedizolid Phosphate may increase the serotonergic activities of Pethidine.
Tedizolid Phosphate
Tedizolid Phosphate may increase the serotonergic activities of Pethidine.
Telaprevir
The risk or severity of adverse effects can be increased when Telaprevir is combined with Pethidine.
Telithromycin
The metabolism of Pethidine can be decreased when combined with Telithromycin.
Temazepam
The risk or severity of adverse effects can be increased when Temazepam is combined with Pethidine.
Terbinafine
The metabolism of Pethidine can be decreased when combined with Terbinafine.
Tetrabenazine
The risk or severity of adverse effects can be increased when Pethidine is combined with Tetrabenazine.
Tetracaine
The risk or severity of adverse effects can be increased when Pethidine is combined with Tetracaine.
Tetracaine hydrochloride
The risk or severity of adverse effects can be increased when Pethidine is combined with Tetracaine.
Tetrahydrocannabinol
Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Pethidine.
Thalidomide
Pethidine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Theobromine
The risk or severity of adverse effects can be increased when Pethidine is combined with Theobromine.
Thiamylal
Thiamylal may increase the central nervous system depressant (CNS depressant) activities of Pethidine.
Thiethylperazine
Thiethylperazine may increase the hypotensive activities of Pethidine.
Thiopental
Thiopental may increase the central nervous system depressant (CNS depressant) activities of Pethidine.
Thiopental Sodium
Thiopental may increase the central nervous system depressant (CNS depressant) activities of Pethidine.
Thioproperazine
Thioproperazine may increase the hypotensive activities of Pethidine.
Thioridazine
The metabolism of Pethidine can be decreased when combined with Thioridazine.
Thiotepa
The metabolism of Pethidine can be decreased when combined with Thiotepa.
Thiothixene
The risk or severity of adverse effects can be increased when Pethidine is combined with Thiothixene.
Tiagabine
The risk or severity of adverse effects can be increased when Pethidine is combined with Tiagabine.
Tiapride
The risk or severity of adverse effects can be increased when Pethidine is combined with Tiapride.
Ticlopidine
The metabolism of Pethidine can be decreased when combined with Ticlopidine.
Tiotropium
The risk or severity of adverse effects can be increased when Tiotropium is combined with Pethidine.
Tipranavir
The risk or severity of adverse effects can be increased when Tipranavir is combined with Pethidine.
Tizanidine
The risk or severity of adverse effects can be increased when Pethidine is combined with Tizanidine.
Tocilizumab
The serum concentration of Pethidine can be decreased when it is combined with Tocilizumab.
Tolcapone
The risk or severity of adverse effects can be increased when Pethidine is combined with Tolcapone.
Toloxatone
Toloxatone may increase the hypotensive and central nervous system depressant (CNS depressant) activities of Pethidine.
Tolterodine
The risk or severity of adverse effects can be increased when Tolterodine is combined with Pethidine.
Tolvaptan
The risk or severity of adverse effects can be increased when Pethidine is combined with Tolvaptan.
Topiramate
The metabolism of Pethidine can be decreased when combined with Topiramate.
Torsemide
The risk or severity of adverse effects can be increased when Pethidine is combined with Torasemide.
Tramadol
The risk or severity of adverse effects can be increased when Tramadol is combined with Pethidine.
Trandolapril
The risk or severity of adverse effects can be increased when Trandolapril is combined with Pethidine.
Tranylcypromine
Tranylcypromine may increase the hypotensive and central nervous system depressant (CNS depressant) activities of Pethidine.
Trazodone
The risk or severity of adverse effects can be increased when Trazodone is combined with Pethidine.
Triamterene
The risk or severity of adverse effects can be increased when Pethidine is combined with Triamterene.
Triazolam
The risk or severity of adverse effects can be increased when Pethidine is combined with Triazolam.
Triazulenone
The risk or severity of adverse effects can be increased when Pethidine is combined with Loprazolam.
Trichlormethiazide
The risk or severity of adverse effects can be increased when Pethidine is combined with Trichlormethiazide.
Trifluoperazine
The risk or severity of adverse effects can be increased when Pethidine is combined with Trifluoperazine.
Triflupromazine
The risk or severity of adverse effects can be increased when Pethidine is combined with Triflupromazine.
Trihexyphenidyl
The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Pethidine.
Trihexyphenidyl Hydrochloride
The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Pethidine.
Trimeprazine
Alimemazine may increase the hypotensive activities of Pethidine.
Trimethaphan
The risk or severity of adverse effects can be increased when Trimethaphan is combined with Pethidine.
Trimipramine
The risk or severity of adverse effects can be increased when Pethidine is combined with Trimipramine.
Triprolidine
The risk or severity of adverse effects can be increased when Pethidine is combined with Triprolidine.
Tropicamide
The risk or severity of adverse effects can be increased when Tropicamide is combined with Pethidine.
Tropisetron
Tropisetron may increase the serotonergic activities of Pethidine.
Trospium
The risk or severity of adverse effects can be increased when Trospium is combined with Pethidine.
Tryptophan
L-Tryptophan may increase the serotonergic activities of Pethidine.
Tubocurarine
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Pethidine.
Umeclidinium
The risk or severity of adverse effects can be increased when Umeclidinium is combined with Pethidine.
Urethane
The risk or severity of adverse effects can be increased when Pethidine is combined with Ethyl carbamate.
Valproate
The risk or severity of adverse effects can be increased when Pethidine is combined with Valproic Acid.
Valproic Acid
The risk or severity of adverse effects can be increased when Pethidine is combined with Valproic Acid.
Vecuronium
The risk or severity of adverse effects can be increased when Vecuronium is combined with Pethidine.
Vemurafenib
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Pethidine.
Venlafaxine
The risk or severity of adverse effects can be increased when Venlafaxine is combined with Pethidine.
Verapamil
The metabolism of Pethidine can be decreased when combined with Verapamil.
Vigabatrin
The risk or severity of adverse effects can be increased when Pethidine is combined with Vigabatrin.
Vilazodone
The risk or severity of adverse effects can be increased when Vilazodone is combined with Pethidine.
Vildagliptin
The risk or severity of adverse effects can be increased when Vildagliptin is combined with Pethidine.
Voriconazole
The metabolism of Pethidine can be decreased when combined with Voriconazole.
Vortioxetine
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Pethidine.
Zaleplon
The risk or severity of adverse effects can be increased when Pethidine is combined with Zaleplon.
Ziconotide
The risk or severity of adverse effects can be increased when Pethidine is combined with Ziconotide.
Ziprasidone
The metabolism of Pethidine can be decreased when combined with Ziprasidone.
Zofenopril
The risk or severity of adverse effects can be increased when Zofenopril is combined with Pethidine.
Zolmitriptan
The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Pethidine.
Zolpidem
Pethidine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Zonisamide
The risk or severity of adverse effects can be increased when Pethidine is combined with Zonisamide.
Zopiclone
The risk or severity of adverse effects can be increased when Pethidine is combined with Zopiclone.
Zotepine
The risk or severity of adverse effects can be increased when Pethidine is combined with Zotepine.
Zuclopenthixol
The risk or severity of adverse effects can be increased when Pethidine is combined with Zuclopenthixol.
